We were so pleased to have the opportunity to address InformaMarkets’ 13 th Annual Pharma IPR Conference in Mumbai on legal challenges to polymorph patents. Patents covering one or more crystalline ...
Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...
Researchers explored a colloidal crystal model to produce specific polymorphs, required for use in materials science and pharmaceuticals. Polymorphs are not mythical, chimeric beasts -- they are ...
MADISON, Wis.--(BUSINESS WIRE)--New research by Usona Institute identifies the most favorable environments to achieve consistency and reproducibility of pharmaceutical psilocybin produced at large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback